Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Stridex

This article was originally published in The Tan Sheet

Executive Summary

Self-Activated Anti-Bacterial Foaming Wash with triclosan 1% promoted via FSI distributed May 16 with coupon for $1 off the $5.49 SRP. Blistex shipped the liquid-to-foam product in January. Print ads are running in Teen People, Teen, YM and Jump. A print ad says the blue fluid "goes from liquid to foam. You go to clean and refreshed." The product's "soothing aloe and natural extracts takes you way beyond clean...to leave your face feeling cool and refreshed like never before." A TV ad shows a young woman using the product while a "God-like" voice says the product leaves skin feeling "kissed by a summer breeze" and "caressed by an angel's wing." The girl interrupts: "How 'bout 'it feels great?'" The voice responds: "OK...That works." The tagline for the product is "A new kind of clean"

You may also be interested in...



Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC

People In Brief

Perrigo promotes in pricing, planning

Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC

Topics

UsernamePublicRestriction

Register

PS143249

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel